Overview

• President Donald Trump linked prenatal paracetamol use to autism and said his administration will recommend limiting Tylenol in pregnancy while seeking updated FDA warnings, also proposing delays and changes to newborn and childhood vaccines.
• The WHO and European Medicines Agency reiterated there is no established causal link between paracetamol use in pregnancy and autism, and major medical groups, including ACOG and the Autism Science Foundation, advised continuing indicated use at the lowest effective dose.
• Large, recent studies—including a Swedish JAMA sibling‑comparison analysis of more than two million births and Norwegian research—reported no association with autism, ADHD or intellectual disability after accounting for family factors.
• Clinicians and ethicists warned that the claims could discourage appropriate treatment of fever in pregnancy and fuel vaccine hesitancy, describing the statements as misinformation that needlessly frightens families.
• In Peru, pharmaceutical and health experts urged the Ministry of Health to reassure the public that paracetamol remains a first‑line option in pregnancy, noting that abrupt discouragement could disrupt care and unsettle the medicines market.